The evidence behind NeuroVive-XR
A snapshot of service evaluations carried out in NHS organisations and research with universities, from the acute stroke unit to the patient’s home.
Platform usage · last updated October 2026
- 11deployment sites, including 7 NHS organisations
- 64participants in NeuroVive-XR studies
- 1,849therapy sessions delivered
- 95 hof VR therapy (5,692 minutes)
- UKCA Class I SaMD
- ISO 13485:2016
- NHS DTAC
- FDA registered
- HIPAA
What happened in practice.
Completed service evaluations in NHS settings and research studies across inpatient, acute and home rehabilitation, including results presented as posters at UK Stroke Forum 2026.
Royal Free London NHS FT
Level 3 inpatient neurorehab · 15 inpatients
UK Stroke Forum 2026 posterSignificant gains in independence and disability alongside VR-supported therapy; 94% of patients would use it again.
CompletedUniversity of Hertfordshire
Home use · stroke · 5 participants
Every participant increased weekly upper-limb exercise at home, by up to 193%, with no withdrawals.Ethics-approved feasibility study
CompletedMid and South Essex NHS FT
Acute stroke unit · 12 patients
UK Stroke Forum 2026 posterHigher therapy intensity and early upper-limb activation; now in routine use after the evaluation.Case study alongside multimodal therapy
CompletedHillingdon Hospitals NHS FT & Brunel University of London
Hospital to home · NHP Innovation Award
Clinician dashboard co-designed with NHS therapists, plus health-economic modelling of a remote VR pathway.
Completedpotential five-year saving for North West London
ModelledNeuroVive VR pathway vs standard care. Brunel University of London, using NICE NG236 and NHS unit costs. Pending real-world validation.
Building the evidence further.
Working with NHS organisations and universities, we are taking NeuroVive-XR into home rehabilitation after discharge, AI-guided self-management and new hardware.
Wearable EMG and FES sleeve
Brunel University London · Electronics, 2025 ↗
A closed-loop prototype combining muscle sensing, electrical stimulation and VR for personalised upper-limb therapy.Read the published paper ↗
PublishedUL MAP VR
Betsi Cadwaladr UHB
UK Stroke Forum 2026 posterThe UL MAP upper-limb self-management programme rebuilt as an immersive demonstrator. Rated acceptable and engaging; Welsh-language delivery also validated.
Phase 1 completeNeuroBike VR
Manchester Metropolitan University, Institute of Sport
Adding VR cognitive gameplay to arm-crank exercise raised exercise intensity compared with the same exercise without VR.7 healthy adults
Phase 1 completeLeeds Teaching Hospitals NHS Trust
Service evaluation · funded by Leeds Hospitals Charity
Evaluating NeuroVive-XR within rehabilitation at Leeds Teaching Hospitals, supported by a Leeds Hospitals Charity Innovation in Healthcare Delivery grant.
OngoingEarly Supported Discharge feasibility study
Betsi Cadwaladr UHB, Wales · Innovate UK RTO scheme
Testing feasibility, adherence and safety of NeuroVive-XR at home within the Early Supported Discharge pathway, with weekly remote review.
OngoingVR mirror therapy and the brain
Laboratory TMS study
Measuring whether gamified VR mirror tasks with haptic feedback engage the motor cortex more than simple movements.
OngoingNeuroMind AI
Reneural · patient education and wellbeing
An AI assistant giving patients key information about their condition, alongside immersive mental health exercises already used in NeuroVive-XR.
In developmentSee the full evidence on a 20-minute call.
We’ll walk you through the studies that match your service, share the full Evaluation and Research Pack, and show NeuroVive-XR in action.